Eli Lilly and Co. et al.; FDA Withdraws Approval of 80 New Drug Applications and 75 Abbreviated New Drug Applications

Summary

The US Food and Drug Administration (FDA) has withdrawn the approval of 80 new drug applications (NDAs) and 75 abbreviated new drug applications (ANDAs) following a request from the applicants, who stated that the corresponding drug products are no longer commercially available in the market.